RICHARD REED LOVE

Summary

Affiliation: The Ohio State University
Country: USA

Publications

  1. pmc Global cancer research initiative
    Richard R Love
    The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
    Cancer Manag Res 2:105-9. 2010
  2. doi request reprint Effects on survival of menstrual cycle phase of adjuvant surgical oophorectomy in premenopausal women with breast cancer
    Richard R Love
    Comprehensive Cancer Center, The Ohio State University, B402 Starling Loving Hall, 320W 10th Ave, Columbus, OH 43210, USA
    Breast Cancer Res Treat 126:479-85. 2011
  3. pmc Adjuvant hormonal therapy in premenopausal women with operable breast cancer: not-so-peripheral perspectives
    Richard R Love
    The Ohio State University Comprehensive Cancer Center Columbus, Ohio, USA
    Oncology (Williston Park) 24:322-7. 2010
  4. doi request reprint Surgical oophorectomy for breast cancer: back to the future
    Richard R Love
    Ohio State University Comprehensive Cancer Center, B402 Starling Loving Hall, 302 W, 10th Ave, Columbus, OH 43210, USA
    Future Oncol 4:785-92. 2008
  5. pmc Defining a global research agenda for breast cancer
    Richard R Love
    Department of Internal Medicine, Division of Hematology Oncology, Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210, USA
    Cancer 113:2366-71. 2008
  6. ncbi request reprint Survival after adjuvant oophorectomy and tamoxifen in operable breast cancer in premenopausal women
    Richard R Love
    Ohio State University, B402 Starling Loving Hall, 320 W 10th Ave, Columbus, OH 43210, USA
    J Clin Oncol 26:253-7. 2008
  7. ncbi request reprint Meeting highlights: International Consensus Panel on the treatment of primary breast cancer
    Richard R Love
    J Clin Oncol 20:879-80. 2002
  8. ncbi request reprint Duration of signs and survival in premenopausal women with breast cancer
    Richard R Love
    Department of Medicine, Section of Medical Oncology, University of Wisconsin School of Medicine, Madison, WI, USA
    Breast Cancer Res Treat 86:117-24. 2004
  9. ncbi request reprint Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women
    Hazel B Nichols
    University of Wisconsin Comprehensive Cancer Center, Madison, WI, USA
    Cancer Epidemiol Biomarkers Prev 14:41-7. 2005
  10. ncbi request reprint Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancer
    Paul R Hutson
    School of Pharmacy, University of Wisconsin, Madison, Wisconsin 53705 2222, USA
    Clin Cancer Res 11:8722-7. 2005

Research Grants

Detail Information

Publications32

  1. pmc Global cancer research initiative
    Richard R Love
    The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
    Cancer Manag Res 2:105-9. 2010
    ..In these contexts, a global cancer research initiative is proposed, and mechanisms for realizing such an effort are suggested...
  2. doi request reprint Effects on survival of menstrual cycle phase of adjuvant surgical oophorectomy in premenopausal women with breast cancer
    Richard R Love
    Comprehensive Cancer Center, The Ohio State University, B402 Starling Loving Hall, 320W 10th Ave, Columbus, OH 43210, USA
    Breast Cancer Res Treat 126:479-85. 2011
    ..5 years of follow-up. The practical and biological implications of these findings deserve rigorous evaluation in clinical trials...
  3. pmc Adjuvant hormonal therapy in premenopausal women with operable breast cancer: not-so-peripheral perspectives
    Richard R Love
    The Ohio State University Comprehensive Cancer Center Columbus, Ohio, USA
    Oncology (Williston Park) 24:322-7. 2010
    ....
  4. doi request reprint Surgical oophorectomy for breast cancer: back to the future
    Richard R Love
    Ohio State University Comprehensive Cancer Center, B402 Starling Loving Hall, 302 W, 10th Ave, Columbus, OH 43210, USA
    Future Oncol 4:785-92. 2008
    ..This combination of circumstances suggests that this first hormonal therapy for breast cancer may once again, have a much greater role globally...
  5. pmc Defining a global research agenda for breast cancer
    Richard R Love
    Department of Internal Medicine, Division of Hematology Oncology, Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210, USA
    Cancer 113:2366-71. 2008
    ..Partnerships of existing organizations in high-income nations with those in low and middle-income countries are currently the most feasible sources of research support...
  6. ncbi request reprint Survival after adjuvant oophorectomy and tamoxifen in operable breast cancer in premenopausal women
    Richard R Love
    Ohio State University, B402 Starling Loving Hall, 320 W 10th Ave, Columbus, OH 43210, USA
    J Clin Oncol 26:253-7. 2008
    ..Longer-term survival benefits from adjuvant therapies in such women with operable breast cancer are unknown...
  7. ncbi request reprint Meeting highlights: International Consensus Panel on the treatment of primary breast cancer
    Richard R Love
    J Clin Oncol 20:879-80. 2002
  8. ncbi request reprint Duration of signs and survival in premenopausal women with breast cancer
    Richard R Love
    Department of Medicine, Section of Medical Oncology, University of Wisconsin School of Medicine, Madison, WI, USA
    Breast Cancer Res Treat 86:117-24. 2004
    ..Overall survival, however, was not significantly different in these two groups...
  9. ncbi request reprint Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women
    Hazel B Nichols
    University of Wisconsin Comprehensive Cancer Center, Madison, WI, USA
    Cancer Epidemiol Biomarkers Prev 14:41-7. 2005
    ..Our findings support the hypothesis that some breast cancer risk factors differ by ER and HER-2/neu tumor marker subtypes...
  10. ncbi request reprint Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancer
    Paul R Hutson
    School of Pharmacy, University of Wisconsin, Madison, Wisconsin 53705 2222, USA
    Clin Cancer Res 11:8722-7. 2005
    ..Clinical trials combining tamoxifen with letrozole or anastrazole have shown minor pharmacokinetic drug interactions. We did an open-label crossover clinical trial of the effect of exemestane on tamoxifen pharmacokinetics...
  11. ncbi request reprint Breast cancer in limited-resource countries: treatment and allocation of resources
    Alexandru Eniu
    Department of Breast Tumors, Oncology, Cancer Institute I Chiricuta, Cluj Napoca, Romania
    Breast J 12:S38-53. 2006
    ..Use of the scheme outlined here should help ministers of health, policymakers, administrators, and institutions in limited-resource settings plan, establish, and gradually expand breast cancer treatment services for their populations...
  12. ncbi request reprint Broadening our perspective on breast cancer
    Richard R Love
    Oncology (Williston Park) 21:524; author reply 524-5. 2007
  13. ncbi request reprint Ornithine decarboxylase (ODC) as a prognostic factor in operable breast cancer
    Richard R Love
    Department of Medicine, Section of Medical Oncology, University of Wisconsin School of Medicine, Madison, WI, USA
    Breast Cancer Res Treat 79:329-34. 2003
    ..Univariate, Kaplan-Meier and multivariate Cox analyses showed no evidence of relationships of ODC by H SCORE to disease-free or overall survival...
  14. ncbi request reprint Postmastectomy radiotherapy in premenopausal Vietnamese and Chinese women with breast cancer treated in an adjuvant hormonal therapy study
    Richard R Love
    Department of Medicine, Section of Medical Oncology, University of Wisconsin School of Medicine, Madison, WI, USA
    Int J Radiat Oncol Biol Phys 56:697-703. 2003
    ..Adjuvant postmastectomy radiotherapy (RT) decreases the risk of local recurrence of breast cancer and may increase overall survival (OS)...
  15. ncbi request reprint Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer
    Richard R Love
    University of Wisconsin Comprehensive Cancer Center, 610 Walnut Street, Madison, WI 53705 2397, USA
    J Clin Oncol 20:2559-66. 2002
    ..Approximately 350,000 new cases of breast cancer are diagnosed annually in premenopausal Asian women who have lower levels of estrogen than western women...
  16. ncbi request reprint Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer
    Richard R Love
    Department of Medicine, Section of Medical Oncology, University of Wisconsin School of Medicine, Madison, 53705, USA
    J Natl Cancer Inst 94:662-9. 2002
    ..We investigated this question in the context of a clinical trial comparing mastectomy alone with mastectomy plus adjuvant oophorectomy and tamoxifen in premenopausal women with operable breast cancer...
  17. ncbi request reprint Breast cancer prevention
    Richard R Love
    University of Wisconsin Medical School, Madison, Wisconsin 53705 2397, USA
    Oncologist 7:100-2. 2002
  18. ncbi request reprint Her-2/neu overexpression and response to oophorectomy plus tamoxifen adjuvant therapy in estrogen receptor-positive premenopausal women with operable breast cancer
    Richard R Love
    Departments of Medicine and Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI 53726, USA
    J Clin Oncol 21:453-7. 2003
    ....
  19. ncbi request reprint Treatment of breast cancer in countries with limited resources
    Robert W Carlson
    Department of Medicine, Stanford University, Stanford, California 94305, USA
    Breast J 9:S67-74. 2003
    ..Efforts to reduce the number of breast cancers diagnosed at an advanced stage thus have the potential to improve rates of survival while decreasing the use of limited resources...
  20. ncbi request reprint Meeting highlights: International consensus panel on the treatment of primary breast cancer
    Richard R Love
    J Clin Oncol 20:1955-6; author reply 1956-7. 2002
  21. ncbi request reprint Young age as an adverse prognostic factor in premenopausal women with operable breast cancer
    Richard R Love
    Department of Medicine, University of Wisconsin, University of Wisconsin Comprehensive Cancer Center, Madison, USA
    Clin Breast Cancer 2:294-8. 2002
    ..Thus, despite efficacy of the combined adjuvant hormonal therapy, younger age was a risk factor for poorer survival...
  22. ncbi request reprint Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer
    Howard H Bailey
    University of Wisconsin Paul P Carbone Comprehensive Cancer Center, 600 Highland Avenue K4 6 CSC, Madison, WI 53792, USA
    Cancer Chemother Pharmacol 62:149-57. 2008
    ..We conducted a phase II multi-institutional study of oral POH administered four times daily in women with advanced treatment-refractory breast cancer...
  23. ncbi request reprint Trait anxiety and tamoxifen effects on bone mineral density and sex hormone- binding globulin
    Linda D Cameron
    Department of Psychology, Faculty of Science, University of Auckland, Auckland, New Zealand
    Psychosom Med 64:612-20. 2002
    ..We assessed whether trait anxiety, a factor linked with a reactive endocrine system, is associated with differential changes in BMD and SHBG levels in response to tamoxifen therapy...
  24. ncbi request reprint Population health, global bioethics and breast cancer treatment
    Richard R Love
    Oncology (Williston Park) 20:675. 2006
  25. ncbi request reprint Oophorectomy for breast cancer: history revisited
    Richard R Love
    Department of Medicine, Section of Medical Oncology, University of Wisconsin School of Medicine, Madison
    J Natl Cancer Inst 94:1433-4. 2002
  26. ncbi request reprint Re: The influence of menstrual cycle phase on surgical treatment of primary breast cancer: have we made any progress over the past 13 years?
    Richard R Love
    J Natl Cancer Inst 94:1722-3; author reply 1723. 2002
  27. ncbi request reprint Endocrine effects of tamoxifen plus exemestane in postmenopausal women with breast cancer
    Richard R Love
    Department of Medicine, University of Wisconsin, 610 Walnut Street, 256 Warf Office Building, Madison, WI 53726, USA
    Clin Cancer Res 11:1500-3. 2005
    ..To evaluate the endocrine effects of the combination of exemestane and tamoxifen, we studied 33 postmenopausal women disease-free following primary treatments for breast cancer who were taking tamoxifen for at least 3 months...
  28. ncbi request reprint Dilemmas in geriatrics: scenario 6 results
    D J Torgerson
    University of York
    WMJ 101:13. 2002
  29. ncbi request reprint Models of breast cancer growth and investigations of adjuvant surgical oophorectomy
    Richard R Love
    Department of Medicine, University of Wisconsin School of Medicine, 610 Walnut St, 256 WARF Bldg, Madison, WI 53726 2397, USA
    Ann Surg Oncol 11:818-28. 2004
    ..Clinical trials and laboratory mechanistic investigations based on these data and observations can determine the potential impact of therapeutic interventions targeting host system macro and micro tumor cell environments...
  30. ncbi request reprint Breast cancer from a public health perspective
    Richard R Love
    Department of Medicine, University of Wisconsin, and University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, USA
    Breast J 10:136-40. 2004
    ..Public health perspectives thus suggest that many current "standard" approaches to breast cancer in Western countries cannot help the majority of women in the world...
  31. ncbi request reprint Surgical oophorectomy and breast cancer incidence
    Richard R Love
    Oncology (Williston Park) 17:1328; author reply 1328-9. 2003
  32. ncbi request reprint Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study
    Syed K Mohsin
    The Breast Center, Baylor College of Medicine, Houston, TX 77030, USA
    Mod Pathol 17:1545-54. 2004
    ..Progesterone receptor assessed by immunohistochemistry provides useful information about clinical outcome and it is better than progesterone receptor measured by ligand-binding assay...

Research Grants18

  1. Luteal Adjuvant Oophorectomy in Vietnamese Breast Cancer
    Richard Love; Fiscal Year: 2007
    ..The investigators will meet accepted and new ethical requirements for this research. A multidisciplinary data monitoring committee will oversee the study. ..
  2. ADJUVANT HORMONAL THERAPY IN VIETNAMESE BREAST CANCER
    Richard Love; Fiscal Year: 2004
    ..The investigators have a trial with a rich database and systems to develop further useful data on breast cancer relevant to all women. ..
  3. ADJUVANT HORMONAL THERAPY IN VIETNAMESE BREAST CANCER
    Richard Love; Fiscal Year: 2002
    ....
  4. Luteal adjuvant oophorectomy in asian breast cancer
    RICHARD REED LOVE; Fiscal Year: 2010
    ..If the improvement in treatment tested works, this will have major implications for treatment of breast cancer and other solid tumors generally. ..